<http://schema.org/description>
"Data from a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates the vast inequalities in access to biologics for the treatments of rheumatoid arthritis (RA) across 46 European countries, with 22% (n=10) of countries having no biologic reimbursed at all."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-06-one-quarter-european-countries-access-biologics.html>